Smart tests aim to outsmart advanced cancers
NCT ID NCT06630325
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tested a precision medicine approach for people with advanced cancers (breast, ovarian, pancreatic, prostate, or sarcoma). Researchers used genetic and protein tests to track how each person's cancer changed over time, then a team of experts recommended personalized drugs. The goal was to see if this tailored strategy could effectively control the disease, though the study was stopped early with only 6 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.